Prognostic implications of left ventricular global longitudinal strain in patients with bicuspid aortic valve disease

William K F Kong1,2, E Mara Vollema1, Francesca Prevedello1

  • 1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Insights

Impaired left ventricular global longitudinal strain (GLS) is common in bicuspid aortic valve (BAV) patients with normal ejection fraction and predicts adverse events like aortic valve replacement.

Area of Science:

  • Cardiology
  • Echocardiography
  • Valvular Heart Disease

Background:

  • Bicuspid aortic valve (BAV) is a common congenital heart defect.
  • Left ventricular (LV) ejection fraction (EF) is often preserved in BAV patients.
  • Prognostic implications of impaired LV global longitudinal strain (GLS) in BAV with preserved LVEF are not well understood.

Purpose of the Study:

  • To evaluate the frequency and prognostic significance of impaired LV GLS in patients with BAV and preserved LVEF.
  • To assess the association between LV GLS and cardiovascular events in this population.

Main Methods:

  • A cohort of 513 BAV patients with preserved LVEF (>50%) was analyzed.
  • Patients were categorized based on BAV dysfunction severity (normal, mild AS/AR, moderate/severe isolated AS, moderate/severe isolated AR, moderate/severe mixed AS/AR).
  • LV GLS was measured using 2D speckle-tracking echocardiography, with impaired function defined as LVGLS ≤ -13.6%.

Main Results:

  • The prevalence of impaired LV GLS varied across BAV dysfunction groups, being highest in normal BAV (97%) and lowest in moderate/severe mixed AS/AR (79%).
  • Over a median of 10 years, 41% underwent aortic valve replacement and 3% died.
  • Impaired LV GLS (>-13.6%) was independently associated with a significantly higher risk of adverse events, primarily aortic valve replacement (HR 1.09, P<0.001).

Conclusions:

  • Impaired LV GLS is a frequent finding in BAV patients with preserved LVEF.
  • LV GLS is an independent predictor of adverse cardiovascular events, including aortic valve replacement, in this patient group.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
347
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
358
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
184
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
348
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
419
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
349